Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-141444
Filing Date
2019-05-08
Accepted
2019-05-08 16:21:10
Documents
68
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d694118d10q.htm 10-Q 847651
2 EX-10.2 d694118dex102.htm EX-10.2 68086
3 EX-10.3 d694118dex103.htm EX-10.3 43907
4 EX-31.1 d694118dex311.htm EX-31.1 9984
5 EX-31.2 d694118dex312.htm EX-31.2 9887
6 EX-32.1 d694118dex321.htm EX-32.1 6817
  Complete submission text file 0001193125-19-141444.txt   4613398

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snna-20190331.xml EX-101.INS 625257
8 XBRL TAXONOMY EXTENSION SCHEMA snna-20190331.xsd EX-101.SCH 52570
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snna-20190331_cal.xml EX-101.CAL 58396
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snna-20190331_def.xml EX-101.DEF 223282
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snna-20190331_lab.xml EX-101.LAB 502449
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snna-20190331_pre.xml EX-101.PRE 357262
Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Filer) CIK: 0001656328 (see all company filings)

EIN.: 273364627 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38155 | Film No.: 19806888
SIC: 2834 Pharmaceutical Preparations